|
|
||||||||
AJP - Heart and Circulatory Physiology, Vol 271, Issue 3 924-H930, Copyright © 1996 by American Physiological Society
ARTICLES |
T. S. Jackson, E. Lerner, R. M. Weisbrod, M. Tajima, J. Loscalzo and J. F. Keaney Jr
Evans Memorial Department of Medicine, Boston University School of Medicine 02118, USA.
Maxadilan is a peptide from the salivary gland of the sand fly Lutzomyia longipalpis, a vector for leishmaniasis. Cutaneous injection of femtomolar quantities of maxadilan produces long-lasting erythema, making it the most potent vasodilator known. Isolated rabbit thoracic and abdominal aorta, carotid artery, and iliac artery demonstrated dose-dependent arterial relaxation in response to maxadilan with a mean effective concentration (EC50) of 2.7 +/- 1.5, 2.1 +/- 0.5, 2.6 +/- 0.4, and 1.9 +/- 0.5 nM, respectively. Maxadilan proved to be at least sevenfold more potent than nitroglycerin in each arterial bed (EC50 = 25 +/- 12, 32 +/- 9, 37 +/- 10, and 22 +/- 13 nM, respectively; P < 0.05 for each vs. maxadilan). Arterial relaxation to maxadilan was independent of endothelium and was equipotent in the thoracic and abdominal aorta, carotid artery, and iliac artery. Arterial relaxation to maxadilan was not inhibited by K(+)-channel antagonists, methylene blue, quinacrine, or ouabain. Maxadilan-mediated arterial relaxation was found to be adenosine 3',5'-cyclic monophosphate (cAMP) dependent, as it was potentiated by the phosphodiesterase inhibitors 3-isobutyl-1-methylxanthine and theophylline, and it was inhibited by the protein kinase A inhibitor H-89. Consistent with this observation, incubation of thoracic aorta with maxadilan (0.1 microM) produced a time-dependent increase in arterial cAMP content coincident with arterial relaxation. Using rabbit aortic smooth muscle cells, we also observed a time-dependent reduction in intracellular calcium in response to maxadilan. Thus these data indicate that maxadilan, a peptide from the sand fly salivary gland, is a potent vasodilator that reduces intracellular calcium through a cAMP-dependent mechanism.
This article has been cited by other articles:
![]() |
A. Huang, H. Xiao, J. M. Samii, J. A. Vita, and J. F. Keaney Jr. Contrasting effects of thiol-modulating agents on endothelial NO bioactivity Am J Physiol Cell Physiol, August 1, 2001; 281(2): C719 - C725. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Xu, J. A. Vita, and J. F. Keaney Jr Ascorbic Acid and Glutathione Modulate the Biological Activity of S-Nitrosoglutathione Hypertension, August 1, 2000; 36(2): 291 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Shapira, A. Xu, G. S. Aldea, J. A. Vita, R. J. Shemin, and J. F. Keaney Jr Enhanced Nitric Oxide-Mediated Vascular Relaxation in Radial Artery Compared With Internal Mammary Artery or Saphenous Vein Circulation, November 9, 1999; 100 (2009): II-322 - II-327. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Shapira, A. Xu, J. A. Vita, G. S. Aldea, N. Shah, R. J. Shemin, and J. F. Keaney Jr NITROGLYCERIN IS SUPERIOR TO DILTIAZEM AS A CORONARY BYPASS CONDUIT VASODILATOR J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 906 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Huang, J. A. Vita, R. C. Venema, and J. F. Keaney Jr. Ascorbic Acid Enhances Endothelial Nitric-oxide Synthase Activity by Increasing Intracellular Tetrahydrobiopterin J. Biol. Chem., June 2, 2000; 275(23): 17399 - 17406. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |